Published in Cancer Epidemiol Biomarkers Prev on December 01, 1997
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health (2000) 2.26
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark (2007) 1.76
Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health (2006) 1.62
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis. World J Gastroenterol (2009) 1.55
Racial disparities in stage-specific colorectal cancer mortality: 1960-2005. Am J Public Health (2010) 1.51
Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial. J Clin Oncol (2009) 1.32
Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst (2011) 1.12
The combined effect of individual and neighborhood socioeconomic status on cancer survival rates. PLoS One (2012) 1.12
High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer (2005) 1.09
Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis. Br J Cancer (2003) 1.03
Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries. Dig Dis Sci (2002) 1.02
Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc (2006) 0.99
A 50-year review of colorectal cancer in African Americans: implications for prevention and treatment. Dig Dis Sci (2009) 0.97
Colorectal cancer in alaska native people, 2005-2009. Gastrointest Cancer Res (2012) 0.95
Prevalence and distribution of adenomas in black Americans undergoing colorectal cancer screening. Dig Dis Sci (2011) 0.91
Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res (2014) 0.90
Racial differences in colorectal cancer survival in the Detroit Metropolitan Area. Cancer (2009) 0.88
Molecular staging of node negative patients with colorectal cancer. J Cancer (2013) 0.86
Social, prognostic, and therapeutic factors associated with cancer survival: a population-based study in metropolitan Detroit, Michigan. J Health Care Poor Underserved (2003) 0.82
Do adverse histopathologic findings in colorectal cancer patients explain disparate outcomes? J Natl Med Assoc (2006) 0.82
Racial differences and disparities in cancer care and outcomes: where's the rub? Surg Oncol Clin N Am (2012) 0.81
Colonoscopic screening for colon cancer. Surg Endosc (2006) 0.81
Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer (2011) 0.81
Guanylyl cyclase C as a biomarker in colorectal cancer. Biomark Med (2013) 0.79
Colorectal Cancer in African Americans: An Update. Clin Transl Gastroenterol (2016) 0.78
GUCY2C molecular staging personalizes colorectal cancer patient management. Biomark Med (2012) 0.78
Marked Variations in Colon Cancer Epidemiology: Sex-specific and Race/Ethnicity-specific Disparities. Gastroenterology Res (2009) 0.75
Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J (1964) 35.63
The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J (1965) 30.51
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Racial Differences in Physical and Mental Health: Socio-economic Status, Stress and Discrimination. J Health Psychol (1997) 12.95
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Do obese children become obese adults? A review of the literature. Prev Med (1993) 7.30
A Rare Disease in Two Brothers. Proc R Soc Med (1917) 6.40
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst (1994) 6.37
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol (1997) 6.35
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Genetic and fossil evidence for the origin of modern humans. Science (1988) 5.78
The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med (1993) 5.39
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA (2001) 5.28
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer (2000) 4.89
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst (1998) 4.72
Estimation of molecular size and molecular weights of biological compounds by gel filtration. Methods Biochem Anal (1970) 4.48
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst (1997) 4.32
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst (2001) 4.26
Neighborhood disadvantage, stress, and drug use among adults. J Health Soc Behav (2001) 4.13
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol (1998) 3.94
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol (1990) 3.89
Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol (1997) 3.57
Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst (1996) 3.52
Sensitivity to ampicillin and cephalothin of enzymes involved in wall peptide crosslinking in Escherichia coli K12, strain 44. Eur J Biochem (1974) 3.43
Glycopeptide resistance in enterococci. Trends Microbiol (1996) 3.42
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Cloning and expression of methicillin resistance from Staphylococcus epidermidis in Staphylococcus carnosus. Antimicrob Agents Chemother (1988) 3.30
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst (1999) 3.19
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer (1998) 2.94
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst (1998) 2.85
Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol (1996) 2.84
American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer (2000) 2.80
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53
Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6. Proc Natl Acad Sci U S A (1991) 2.53
Are aortic aneurysms caused by atherosclerosis? Circulation (1992) 2.52
VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother (1997) 2.50
Cancer incidence and mortality, 1973-1995: a report card for the U.S. Cancer (1998) 2.48
Cloning and sequence analysis of the Saccharomyces cerevisiae RAD9 gene and further evidence that its product is required for cell cycle arrest induced by DNA damage. Mol Cell Biol (1989) 2.43
Isolation and characterization of the RAD3 gene of Saccharomyces cerevisiae and inviability of rad3 deletion mutants. Proc Natl Acad Sci U S A (1983) 2.38
Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst (1995) 2.36
RAD6 gene of Saccharomyces cerevisiae encodes a protein containing a tract of 13 consecutive aspartates. Proc Natl Acad Sci U S A (1985) 2.32
Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25
Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol (1999) 2.23
The nucleotide sequence of the RAD3 gene of Saccharomyces cerevisiae: a potential adenine nucleotide binding amino acid sequence and a nonessential acidic carboxyl terminal region. Nucleic Acids Res (1985) 2.18
Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol (1996) 2.17
Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust (1989) 2.16
Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group. J Natl Cancer Inst (1992) 2.15
Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd (1977) 2.12
The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene (1995) 2.09
Fractionation of the DD-carboxypeptidase-transpeptidase activities solubilized from membranes of Escherichia coli K12, strain 44. Eur J Biochem (1974) 2.06
Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA (1994) 2.04
Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol (1989) 2.03
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Staging laparotomy in early ovarian cancer. JAMA (1983) 2.02
A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med (1989) 1.99
The chemistry of xanthine oxidase. 11. Ultracentrifuge and gel-filtration studies on the milk enzyme. Biochem J (1964) 1.95
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother (1999) 1.95
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J Clin Oncol (1983) 1.94
Low doses of radiation increase the latency of spontaneous lymphomas and spinal osteosarcomas in cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res (2003) 1.92
Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst (1992) 1.88
Changes in vascular endothelium related to lymphocyte collections in diseased synovia. Arthritis Rheum (1983) 1.88
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Purification and characterization of the Saccharomyces cerevisiae RAD1/RAD10 endonuclease. J Biol Chem (1993) 1.87
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15. J Natl Cancer Inst (2000) 1.85
Psychosocial and physical outcomes of primary breast cancer therapy: mastectomy vs excisional biopsy and irradiation. Breast Cancer Res Treat (1983) 1.80
Histone-histone propinquity by aldehyde fixation of chromatin. Proc Natl Acad Sci U S A (1975) 1.79
Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1992) 1.77
The use of informal and formal help: four patterns of illness behavior in the black community. Am J Community Psychol (1984) 1.77
Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology (1997) 1.76
Demographic and geographic variability of kidney stones in the United States. Kidney Int (1994) 1.75
Body size and breast cancer risk among women under age 45 years. Am J Epidemiol (1996) 1.75
Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1996) 1.75
Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control (2000) 1.75
Validation of the American Cancer Society Cancer Prevention Study II Nutrition Survey Cohort Food Frequency Questionnaire. Epidemiology (2000) 1.73
Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis. Cancer (1998) 1.73
Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01. J Natl Cancer Inst (1988) 1.72
Agricultural pesticide use in California: pesticide prioritization, use densities, and population distributions for a childhood cancer study. Environ Health Perspect (2001) 1.70